{"id":"https://openalex.org/W2003014193","doi":"https://doi.org/10.1111/j.1365-2125.2005.02383.x","title":"Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension","display_name":"Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension","alternate_titles":[],"publication_year":2005,"publication_date":"2005-03-30","ids":{"openalex":"https://openalex.org/W2003014193","doi":"https://doi.org/10.1111/j.1365-2125.2005.02383.x","mag":"2003014193","pmid":"https://pubmed.ncbi.nlm.nih.gov/15963102","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1884910"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.2005.02383.x","doi":"https://doi.org/10.1111/j.1365-2125.2005.02383.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2005.02383.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2005.02383.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2003014193"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2005.02383.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070591172","display_name":"Gideon A. Paul","orcid":"https://orcid.org/0000-0003-0000-2228","observed_orcids":["https://orcid.org/0000-0003-0000-2228"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gideon A. Paul","raw_affiliation_strings":["Experimental Medicine & Toxicology, Imperial College London, London, UK","Experimental Medicine & Toxicology, Imperial College London, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Medicine & Toxicology, Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medicine & Toxicology, Imperial College London, and","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026902884","display_name":"J. Simon R. Gibbs","orcid":"https://orcid.org/0000-0001-6147-9252","observed_orcids":["https://orcid.org/0000-0001-6147-9252"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Simon R. Gibbs","raw_affiliation_strings":["Department of Cardiology, Hammersmith Hospital, Du Cane Road, London, W12 ONN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Hammersmith Hospital, Du Cane Road, London, W12 ONN, UK","institution_ids":["https://openalex.org/I2801748203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071905126","display_name":"Alan R. Boobis","orcid":"https://orcid.org/0000-0003-3371-386X","observed_orcids":["https://orcid.org/0000-0003-3371-386X"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan R. Boobis","raw_affiliation_strings":["Experimental Medicine & Toxicology, Imperial College London, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Medicine & Toxicology, Imperial College London, and","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067260773","display_name":"Allifia Abbas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Allifia Abbas","raw_affiliation_strings":["Experimental Medicine & Toxicology, Imperial College London, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Medicine & Toxicology, Imperial College London, and","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091252848","display_name":"Martin R. Wilkins","orcid":"https://orcid.org/0000-0003-3926-1171","observed_orcids":["https://orcid.org/0000-0003-3926-1171"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Martin R. Wilkins","raw_affiliation_strings":["Experimental Medicine & Toxicology, Imperial College London, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Medicine & Toxicology, Imperial College London, and","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5091252848"],"corresponding_institution_ids":["https://openalex.org/I47508984"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":14.8416,"has_fulltext":true,"cited_by_count":235,"citation_normalized_percentile":{"value":0.99234446,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"60","issue":"1","first_page":"107","last_page":"112"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.8833000063896179,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.8833000063896179,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.09839999675750732,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bosentan","display_name":"bosentan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sildenafil","display_name":"sildenafil","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.871999979019165},{"id":"https://openalex.org/keywords/pulmonary-arterial-hypertension","display_name":"pulmonary arterial hypertension","score":0.9909999966621399},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.6570000052452087},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6610000133514404},{"id":"https://openalex.org/keywords/co-administration","display_name":"co-administration","score":0.44200000166893005},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.46299999952316284},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.6159999966621399},{"id":"https://openalex.org/keywords/endothelin-receptor-antagonists","display_name":"endothelin receptor antagonists","score":0.6930000185966492},{"id":"https://openalex.org/keywords/phosphodiesterase-5-inhibitors","display_name":"phosphodiesterase-5 inhibitors","score":0.9440000057220459}],"concepts":[{"id":"https://openalex.org/C2781109936","wikidata":"https://www.wikidata.org/wiki/Q419769","display_name":"Bosentan","level":4,"score":0.9905103445053101},{"id":"https://openalex.org/C2776768464","wikidata":"https://www.wikidata.org/wiki/Q191521","display_name":"Sildenafil","level":2,"score":0.9629258513450623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7764449119567871},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.6009439826011658},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5337366461753845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4821205139160156},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4816816747188568},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4304547905921936},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3366087079048157},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3347775936126709},{"id":"https://openalex.org/C144980905","wikidata":"https://www.wikidata.org/wiki/Q24721308","display_name":"Endothelin receptor","level":3,"score":0.19464319944381714},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068677","descriptor_name":"Sildenafil Citrate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077300","descriptor_name":"Bosentan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006976","descriptor_name":"Hypertension, Pulmonary","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006976","descriptor_name":"Hypertension, Pulmonary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.2005.02383.x","doi":"https://doi.org/10.1111/j.1365-2125.2005.02383.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2005.02383.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2005.02383.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:15963102","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15963102","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1884910","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1884910/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.2005.02383.x","doi":"https://doi.org/10.1111/j.1365-2125.2005.02383.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2005.02383.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2005.02383.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320319992","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04"},{"id":"https://openalex.org/F4320338282","display_name":"Actelion Pharmaceuticals","ror":"https://ror.org/001yedb91"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2003014193.pdf","grobid_xml":"https://content.openalex.org/works/W2003014193.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W139966569","https://openalex.org/W1484324193","https://openalex.org/W1542321037","https://openalex.org/W1558292706","https://openalex.org/W1558901950","https://openalex.org/W1703321169","https://openalex.org/W1956875558","https://openalex.org/W1974227996","https://openalex.org/W1989792368","https://openalex.org/W2027202120","https://openalex.org/W2030825915","https://openalex.org/W2045150258","https://openalex.org/W2048443661","https://openalex.org/W2067180666","https://openalex.org/W2090659780","https://openalex.org/W2103058477","https://openalex.org/W2148965526","https://openalex.org/W2168113891"],"related_works":["https://openalex.org/W2075746894","https://openalex.org/W2063196513","https://openalex.org/W2412586810","https://openalex.org/W4249723334","https://openalex.org/W2095984197","https://openalex.org/W1959553344","https://openalex.org/W2238042687","https://openalex.org/W2141841707","https://openalex.org/W3029853093","https://openalex.org/W1977021063"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"determine":[2],"whether":[3],"bosentan":[4,33,61,72,128,159,191,257,273],"decreases":[5,284],"the":[6,66,150,156,177,249,255,285],"plasma":[7,87,250,265,286],"concentration":[8,287],"of":[9,68,71,158,188,196,252,267,288],"sildenafil":[10,143,171,253,289],"in":[11,27,86,142,149,170,176,248,274],"patients":[12,19,293],"with":[13,23,127,138,294],"pulmonary":[14,24,295],"arterial":[15,25],"hypertension.":[16,296],"METHODS:":[17],"Ten":[18],"(aged":[20],"39-77":[21],"years)":[22],"hypertension":[26],"WHO":[28],"functional":[29],"class":[30],"III":[31],"received":[32],"62.5":[34,129,183],"mg":[35,43,52,130,162,184],"twice":[36,44,131,163],"daily":[37,45,132,164],"for":[38,46,133,207,216],"1":[39,198,231],"month,":[40],"then":[41],"125":[42,161],"a":[47,56,139,146,167,245,275],"second":[48],"month.":[49],"Sildenafil":[50,78,222],"100":[51],"was":[53,114,136,199,244,269],"given":[54],"as":[55],"single":[57],"dose":[58,157,258],"before":[59],"starting":[60],"(visit":[62],"1)":[63],"and":[64,76,79,91,104,145,174,210,242,264],"at":[65,88],"end":[67],"each":[69],"month":[70],"treatment":[73,192],"(visits":[74],"2":[75,209],"3).":[77],"its":[80],"primary":[81],"metabolite,":[82],"desmethylsildenafil,":[83],"were":[84],"measured":[85],"0":[89],"h":[90,106],"0.25,":[92],"0.5,":[93],"1,":[94],"1.5,":[95],"2,":[96],"3,":[97],"4,":[98],"6,":[99],"8,":[100],"10,":[101],"12,":[102],"18":[103],"24":[105],"using":[107,119],"liquid":[108],"chromatography-tandem":[109],"mass":[110],"spectrometry.":[111],"Statistical":[112],"analysis":[113],"by":[115,272],"repeated":[116],"measures":[117],"anova,":[118],"log":[120],"transformed":[121],"data":[122],"where":[123],"appropriate.":[124],"RESULTS:":[125],"Treatment":[126],"4":[134],"weeks":[135],"associated":[137],"two-fold":[140],"increase":[141,169],"clearance/F":[144],"50%":[147],"decrease":[148,175,247],"AUC":[151,178,189,263],"(P":[152,179,219,239,259,278],"<":[153,180,220,240,260,279],"0.001).":[154,221],"Increasing":[155],"to":[160,166,194,232,292],"led":[165],"further":[168],"oral":[172],"clearance":[173],"0.001":[181],"vs.":[182],"bosentan).":[185],"The":[186,262],"ratio":[187],"on":[190,229,236,254],"relative":[193],"that":[195],"visit":[197,208,217,230,237],"0.47":[200],"[95%":[201],"confidence":[202],"interval":[203],"(CI)":[204],"0.36,":[205],"0.61]":[206],"0.31":[211],"(95%":[212],"CI":[213],"0.23,":[214],"0.41)":[215],"3":[218,238],"C(max)":[223],"fell":[224],"from":[225],"759":[226],"ng":[227,234],"ml(-1)":[228,235],"333":[233],"0.01)":[241],"there":[243],"significant":[246],"half-life":[251,266],"higher":[256],"0.05).":[261],"desmethylsildenafil":[268],"also":[270],"decreased":[271],"dose-dependent":[276],"manner":[277],"0.01).":[280],"CONCLUSIONS:":[281],"Bosentan":[282],"significantly":[283],"when":[290],"coadministered":[291]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2003014193","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
